XENO (Xeno Transplants) Marketable Securities: $0.00 Mil (As of Mar. 2008)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Xeno Transplants Marketable Securities?

Xeno Transplants XENO Marketable Securities is $0.00 Mil as of Mar. 2008.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Xeno Transplants's Marketable Securities for the quarter that ended in Mar. 2008 was $0.00 Mil.

Xeno Transplants  (OTCPK:XENO) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Xeno Transplants Marketable Securities Related Terms

Xeno Transplants Marketable Securities Historical Data

* Premium members only.

The historical data trend for Xeno Transplants's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Xeno Transplants Marketable Securities Chart

Xeno Transplants Annual Data
Trend Jun05 Jun06 Jun07
Marketable Securities
0.00 0.00 0.00

Xeno Transplants Quarterly Data
Jun05 Sep05 Dec05 Mar06 Jun06 Sep06 Dec06 Mar07 Jun07 Sep07 Dec07 Mar08
Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Xeno Transplants Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Frequently Asked Questions Learn more about Marketable Securities →
What does a Marketable Securities of $0.00 Mil mean?
Xeno Transplants (XENO) has a Marketable Securities of $0.00 Mil as of Mar. 2008. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Xeno Transplants and its competitors.
Is Xeno Transplants' Marketable Securities too high?
Xeno Transplants' current Marketable Securities is $0.00 Mil.
How does Xeno Transplants' Marketable Securities compare to PRTX and GWSN?
Xeno Transplants' Marketable Securities of $0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Marketable Securities for a Biotechnology company?
A good Marketable Securities depends on the Biotechnology industry context. However, Marketable Securities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Marketable Securities mean?
A high Marketable Securities can signal that a stock is expensive relative to its fundamentals. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Xeno Transplants and its competitors. Xeno Transplants's current Marketable Securities is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Xeno Transplants stock overvalued right now?
Xeno Transplants (XENO) has a current Marketable Securities of $0.00 Mil. The current Marketable Securities is $0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Marketable Securities calculated?
Marketable Securities is calculated from a company's financial statements. For Xeno Transplants (XENO), the current Marketable Securities is $0.00 Mil as of Mar. 2008. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Xeno Transplants Business Description

Address 143 Gardner Road, Brookline, MA, USA, 02445
Xeno Transplants Corp is a bio-technology research and development company, which intends to develop therapeutic applications of organs and cells derived from genetically engineered pigs as a transplant alternative to limited human donor sources.